Labiotech.eu

News and Trends 24 Apr 2016

What happened this week? Top 10 London Biotechs, CRISPR, AACR

1. Here are 10 Awesome London based Biotechs 2. ITW: This Biotech Startup wants to fix Youth Blindness with a Gene Therapy 3. These EU Biotechs presented groundbreaking results at World Biggest Cancer Meeting 4. New CRISPR Tool can cut RNA too: Gene Editing just got even Easier! 5. Who are France’s Young Innovators in […]

April 24, 2016 - 1 minutemin - By Philip Hemme

Katharine dowson bioart science gallery hiv brain malformation glass

News and Trends 23 Apr 2016

BioArt : Katharine Dowson’s Brain Boxes, Crystal Chromosomes & HIV Vaccine Work

Represented by the GV Art Gallery in London, Katharine Dowson is a glass sculptor who is well established in the BioArt community as an Anatomical and medicine specialist. Katharine studied at the Royal College of Art and Camberwell in London, with a focus spanning to include the anatomical form (particularly the Nervous system) to infectious diseases and developmental research into a […]

April 23, 2016 - 4 minutesmins - By Dani Bancroft

cannabis cannabidiol gw pharmaceuticals tuberous sclerosis complex epilepsy biotech fda orphan drug trials

News and Trends 22 Apr 2016

UK Cannabis Biotech gets another Orphan Drug Designation by the FDA

Cambridge based GW Pharmaceuticals has now been granted Orphan Drug Designation from FDA for Cannabidiol drug to treat a 3rd rare genetic form of epilepsy. GW Pharmaceuticals has been granted Orphan Drug Designation for cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC). Epidiolex is a liquid formulation of pure plant-derived CBD, which is in development for […]

April 22, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 22 Apr 2016

Biotech of the Week: Covagen, binding proteins to antibodies for Immunotherapy

We say our goodbyes to Belgium this week and head one more time to Switzerland. In Zürich, where you can find almost any kind of cheese, delicious chocolate and a beautiful view of the Swiss Alps near the city lake, is also where Covagen, our Biotech of the Week is located. City: Zürich (Switzerland) Founded: 2007 Employees: 23 (as of […]

April 22, 2016 - 2 minutesmins - By Joachim Eeckhout

saphetor ngs lausanne university hospital endocrine

News and Trends 22 Apr 2016

Swiss Biotech to Investigate rare Endocrine Disorders with NGS

Saphetor is developing genome-scale analysis of next generation sequencing (NGS) results – and will now ‘play’ with real data of Endocrine patients at the Lausanne University Hospital. Based in Lausanne’s EPFL Innovation Park (Switzerland), Saphetor was founded only in 2014 and completed a seed financing round this February, raising around €1M (1.2M CHF). This startup develops proprietary […]

April 22, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 21 Apr 2016

New CRISPR Tool can cut RNA too: Gene Editing just got even Easier!

The research team led by Emannuelle Charpentier, co-discoverer of the CRISPR/Cas9 system, has found that a new CRISPR system can also cleave RNA. Amazingly simple! The discovery of the CRISPR/Cas9 system revolutionised Biotechnology, unlocking a kind of ‘Golden age’ for gene editing – with a wide-reaching impact from therapeutics to SynBio. So, it’s no wonder that […]

April 21, 2016 - 3 minutesmins - By Denise Neves Gameiro

aacr 2016 merus transgene debiopharma innate

News and Trends 21 Apr 2016

These EU Biotechs presented groundbreaking results at World Biggest Cancer Meeting

The annual meeting of the American Association for Cancer Research (AACR) has just finished. From Europe, who made a splash with their results? The AACR annual meeting is the world’s biggest conference in Cancer research, and the must-attend event for Biotechs developing cancer therapies. The 2016 edition took place in New Orleans (US) from the […]

April 21, 2016 - 5 minutesmins - By Denise Neves Gameiro

argenx agx115 abbvie immunooncology biotech deal ucl cancer pharma

News and Trends 21 Apr 2016

Llama Biotech makes €600M deal with AbbVie for Immuno-Oncology

Ghent based argenx has just partnered up with the French AbbVie to develop a novel antibody derived from llamas – in its biggest deal ever! Having been better known for their work into autoimmune diseases, argenx has now also broken into the Immuno-Oncology field – big time. Previous collaborators have included Denmark’s Leo Pharma for inflammatory […]

April 21, 2016 - 2 minutesmins - By Dani Bancroft

novozymes lactase saphera lactose free yogurt

News and Trends 20 Apr 2016

What’s the deal with Lactose free yogurt in Denmark?

Novozymes, the European leader for Industrial Biotech, has had a good start to 2016. It has now launched some new ideas, including for lactose-free food products. Novozymes is a giant in the production of enzymes, an important player in the ‘traditional Biotech’ biocatalysis revolution and a cornerstone in the Danish Biotech scene. The company has now released its financial […]

April 20, 2016 - 3 minutesmins - By Denise Neves Gameiro

nicox ac 170 cetirizine eye drop allergic

News and Trends 20 Apr 2016

French Biotech submits new Drug for Eye Allergies to the FDA

Nicox is filing a New Drug Application for its allergic conjuntivitis candidate, a novel eye drop formulation of a well-known antihistamine. Based in Sophia Antipolis (near the French Riviera), Nicox is developing therapies in ophthalmology. Now, it has submitted one of its candidates (AC-170) for FDA approval, after good results from two phase III trials evaluating both the safety and […]

April 20, 2016 - 2 minutesmins - By Denise Neves Gameiro

stevenage biosciences catalyst catapult appolo MRC biotech

News and Trends 19 Apr 2016

Drug Discovery moves to Stevenage – the new Golden Triangle hotspot?

MRC Technology, a UK medical research charity, has moved most of its labs to the Stevenage Bioscience Catalyst (SBC) campus. Located inside the gold triangle, is this the new hotspot of UK Biotech? MRC Technology provides drug discovery services, as well as advice for commercialisation and intellectual property management, for academia and industry. Since it was founded […]

April 19, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 19 Apr 2016

French Microbiome Therapy boosted by compound from major US Biotech

Enterome, a leader in the European microbiome field, has struck a deal with US’ Vertex to develop novel small molecules with potential to treat inflammatory bowel diseases. With an impressive roll of partnerships and backed by the world-first Microbiome fund, Enterome is very well-positioned in hype field of the Microbiome. We discussed Enterome’s differentiated strategy […]

April 19, 2016 - 3 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

What happened this week? Top 10 London Biotechs, CRISPR, AACR

BioArt : Katharine Dowson’s Brain Boxes, Crystal Chromosomes & HIV Vaccine Work

UK Cannabis Biotech gets another Orphan Drug Designation by the FDA

Biotech of the Week: Covagen, binding proteins to antibodies for Immunotherapy

Swiss Biotech to Investigate rare Endocrine Disorders with NGS

New CRISPR Tool can cut RNA too: Gene Editing just got even Easier!

These EU Biotechs presented groundbreaking results at World Biggest Cancer Meeting

Llama Biotech makes €600M deal with AbbVie for Immuno-Oncology

What’s the deal with Lactose free yogurt in Denmark?

French Biotech submits new Drug for Eye Allergies to the FDA

Drug Discovery moves to Stevenage – the new Golden Triangle hotspot?

French Microbiome Therapy boosted by compound from major US Biotech

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!